BioSpace News Archive

Biotech Bay

Adicet Bio to Present at J.P. Morgan Healthcare Conference

Adicet Bio, Inc., a biopharmaceutical company focused on the development of allogeneic cell therapies for cancer using innovative gamma delta T cells, announced today that the company will present at the 38th Annual J.P. Morgan Healthcare Conference.

January 9, 2020
·
1 min read
Business

Envista Schedules Fourth Quarter 2019 Earnings Call

Envista Holdings Corporation will report financial results for its fourth quarter 2019 on Thursday, January 30, 2020, after market close

January 9, 2020
·
2 min read
Job Trends

Clene Nanomedicine Announces First Patient Dosed in the REPAIR-MS Clinical Trial for the Treatment of Multiple Sclerosis with Lead Nanocatalytic Therapeutic, CNM-Au8

Clene Nanomedicine, Inc. announced the dosing of the first patient enrolled in the Phase 2 REPAIR-MS study with its lead nanocatalytic therapy, CNM-Au8, for the treatment of Multiple Sclerosis.

January 9, 2020
·
4 min read
Phagelux to Present at Biotech Showcase 2020 in San Francisco

Phagelux, Inc., a clinical-stage ready biotechnology company focused on the discovery and development of bacteriophages and lysins to treat and prevent antibiotic resistant infections, today announced that it has scheduled a company presentation at Biotech Showcase 2020

January 9, 2020
·
1 min read
Genetown

Karuna Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Karuna Therapeutics, Inc. announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will present at the 38th Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, CA.

January 9, 2020
·
1 min read
Business

Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Using Arestat™ TechnologyProduct designed to provide safer, more immediate treatment option for patients

Hikma Pharmaceuticals PLC and Arecor Ltd announce they have entered into an exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US through Hikma’s affiliate, Hikma Pharmaceuticals USA Inc.

January 9, 2020
·
4 min read
Biotech Bay

OBI Pharma, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference

OBI Pharma, Inc., a Taiwan biopharma company, announced that Michael Chang, Ph.D. Chairman and CEO, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2019 at 4:30 p.m. PST/ 7:30 p.m EST, in San Francisco, CA.

January 9, 2020
·
2 min read
BioCapital

Danaher To Present At The 38th Annual J.P. Morgan Healthcare Conference

Danaher Corporation announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2020 at 8:00 a.m. PT.

January 9, 2020
·
1 min read
Deals

Synlogic Outlines Upcoming Milestones for Clinical Programs and Unveils New Preclinical Pipeline Programs

First subject treated in SYNB1891 immuno-oncology study, data from monotherapy arm expected in 2020

January 9, 2020
·
9 min read
Business

Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform

Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform

January 9, 2020
·
2 min read